QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
LON:IBT

International Biotechnology Trust (IBT) Share Forecast, Price & News

GBX 668
-5.00 (-0.74%)
(As of 06/8/2023 ET)
Compare
Today's Range
664
680
50-Day Range
640
688
52-Week Range
588
744
Volume
20,697 shs
Average Volume
50,929 shs
Market Capitalization
£271.21 million
P/E Ratio
N/A
Dividend Yield
4.19%
Price Target
N/A

IBT stock logo

About International Biotechnology Trust (LON:IBT) Stock

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology Trust and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

IBT.L - International Biotechnology Trust plc
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Ian Cowie: Five investment reasons to be cheerful
Int.biotech. Share Chat
International Biotechnology Trust plc (IBT.L)
Trade-Van Information Services Co. Ltd.
International Biotechnology Trust plc (IBT)
See More Headlines

IBT Price History

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Sector
Finance
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£-22,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£-13,580,000.00
Cash Flow
GBX 4.31 per share
Book Value
GBX 697 per share

Miscellaneous

Free Float
N/A
Market Cap
£272.34 million
Optionable
Not Optionable
Beta
0.24

Key Executives

  • Ms. Lucy Costa Duarte
    Head of Investor Relations
  • Ms. Catherine Elizabeth Bingham M.B.A. (Age 57)
    Managing Partner
  • Ms. Ailsa Craig
    Investment Mang.
  • Mr. Marek Poszepczynski M Sci Eng
    Investment Mang.
  • Claire Jackson
    Company Sec.
  • Dr. Carl Harald Janson
    Lead Investment Mang.













IBT Stock - Frequently Asked Questions

How have IBT shares performed in 2023?

International Biotechnology Trust's stock was trading at GBX 706 on January 1st, 2023. Since then, IBT shares have decreased by 5.0% and is now trading at GBX 670.80.
View the best growth stocks for 2023 here
.

How often does International Biotechnology Trust pay dividends? What is the dividend yield for International Biotechnology Trust?

International Biotechnology Trust announced a dividend on Tuesday, December 6th. Stockholders of record on Thursday, December 29th will be paid a dividend of GBX 14 per share on Friday, January 27th. This represents a yield of 2.01%. The ex-dividend date of this dividend is Thursday, December 29th. The official announcement can be viewed at this link.
Read our dividend analysis for IBT
.

Is International Biotechnology Trust a good dividend stock?

International Biotechnology Trust (LON:IBT) pays an annual dividend of GBX 28 per share and currently has a dividend yield of 4.20%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for IBT.

What other stocks do shareholders of International Biotechnology Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology Trust investors own include Oxford Pharmascience Group (OXP), Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX).

What is International Biotechnology Trust's stock symbol?

International Biotechnology Trust trades on the London Stock Exchange (LON) under the ticker symbol "IBT."

How do I buy shares of International Biotechnology Trust?

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is International Biotechnology Trust's stock price today?

One share of IBT stock can currently be purchased for approximately GBX 670.80.

How much money does International Biotechnology Trust make?

International Biotechnology Trust (LON:IBT) has a market capitalization of £272.34 million and generates £-13,580,000.00 in revenue each year. The company earns £-22,470,000.00 in net income (profit) each year or GBX (0.55) on an earnings per share basis.

How can I contact International Biotechnology Trust?

International Biotechnology Trust's mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The official website for the company is www.ibtplc.com. The company can be reached via phone at 44 20 7421 7070.

This page (LON:IBT) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -